Bioton (WAR:BIO) Net Income From Continuing Operations : zł-2.6 Mil (TTM As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Bioton Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Bioton's net income from continuing operations for the three months ended in Mar. 2024 was zł-5.0 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was zł-2.6 Mil.

Bioton Net Income From Continuing Operations Historical Data

The historical data trend for Bioton's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Net Income From Continuing Operations Chart

Bioton Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-126.69

33.92

2.88

1.42

2.28

Bioton Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.13	1.42	-4.42	5.40	-5.04

Bioton Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-2.6 Mil.

Bioton (WAR:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (WAR:BIO) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

7U5:Germany

Address

Ul. Staro?ci?ska 5, Warszawa, POL, 02-516

Website

http://www.bioton.pl

Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.